Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00022373
Status:
UNKNOWN
Last Update Posted:
2014-10-15
First Post:
2001-08-10
Brief Title:
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Radiation Toxicity |
| Head and Neck Cancer |
| Oral Complications of Radiation Therapy |
Keywords:
| Name | View |
|---|---|
| oral complications of radiation therapy | View |
| stage I nasopharyngeal cancer | View |
| stage II nasopharyngeal cancer | View |
| stage III nasopharyngeal cancer | View |
| stage IV nasopharyngeal cancer | View |
| stage I salivary gland cancer | View |
| stage II salivary gland cancer | View |
| stage III salivary gland cancer | View |
| stage IV salivary gland cancer | View |
| recurrent salivary gland cancer | View |
| untreated metastatic squamous neck cancer with occult primary | View |
| recurrent metastatic squamous neck cancer with occult primary | View |
| stage I lip and oral cavity cancer | View |
| stage II lip and oral cavity cancer | View |
| stage III lip and oral cavity cancer | View |
| stage IV lip and oral cavity cancer | View |
| stage I hypopharyngeal cancer | View |
| stage II hypopharyngeal cancer | View |
| stage III hypopharyngeal cancer | View |
| stage IV hypopharyngeal cancer | View |
| stage I oropharyngeal cancer | View |
| stage II oropharyngeal cancer | View |
| stage III oropharyngeal cancer | View |
| stage IV oropharyngeal cancer | View |
| radiation toxicity | View |